TAG:
cap
Specialty Laboratories, Enterix, Medicare, Blue Cross/Blue Shield Association
By Robert Michel | From the Volume X No. 15 – November 10, 2003 Issue
SPECIALTY LABORATORIES REPORTS THIRD QUARTER FINANCIAL PERFORMANCE THIRD QUARTER FINANCIAL REPORTS for Specialty Laboratories, Inc. show that the company is returning to a more normal routine, following the two unusual and unrelated events which hit it during 2002. Special…
Market Demand for Pathologists Shifts Toward Specialization
By Robert Michel | From the Volume X No. 15 – November 10, 2003 Issue
CEO SUMMARY: Unlike the slack employment market for pathologists seen during the 1990s, there is strong demand for pathologists in this decade. Private pathology group practices now face competition for the best pathology talent. That’s because public lab companies are regularly in the …
Mergers Create Two Huge National Health Insurers
By Robert Michel | From the Volume X No. 15 – November 10, 2003 Issue
ANOTHER ROUND OF CONSOLIDATION among health insurers has created a new “biggest in the nation” company and boosted the size of the second largest health insurance company. On October 28, in separate announcements that were just 30 minutes apart, Anthem Inc. disclosed it would pa…
No Disruptive Technology In Lab Industry’s Future
By Robert Michel | From the Volume X No. 14 – October 20, 2003 Issue
CEO SUMMARY: As new diagnostic technologies move through the development pipeline and into widespread clinical use, the scientific knowledge and skill sets needed by laboratory staff and management will change. The emphasis in laboratory medicine will evolve to include more molecular tech…
Looking at Fast-Growth And Slow-Growth Areas In Diagnostic Testing
By Robert Michel | From the Volume X No. 14 – October 20, 2003 Issue
CEO SUMMARY: This exclusive intelligence briefing predicts how specific new technologies may drive changes in the laboratory-testing marketplace during the next five years. The key message is that change is expected to be incremental, not disruptive—given the technology known to be in d…
“October 20, 2003 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume X No. 14 – October 20, 2003 Issue
Here’s a reminder that corporate fraud didn’t bypass healthcare. Last week Albert Bergonzi, former Executive Vice President of McKesson/HBOC, pled guilty to violations of securities laws. He admitted that he had “cooked the books” around the time of HBOC’s acquisition by Mc…
AP’s “High & Mighty” Firms Hit Tough Times
By Robert Michel | From the Volume X No. 13 – September 29, 2003 Issue
CEO SUMMARY: In the years between 1995 and 2002, public companies AmeriPath, DIANON Systems, and IMPATH built revenues and profits at a blistering pace. During this time period, these three firms captured enough market share to do almost $1 billion of anatomic pathology business in 2002. …
Entrepreneur Offers Private Pay Autopsies
By Robert Michel | From the Volume X No. 13 – September 29, 2003 Issue
CEO SUMMARY: For the past 14 years, a non-pathologist entrepreneur has enjoyed a growing business in offering autopsy services to clients willing to pay out-of-pocket. By design, the business is limited to the Southern California region. But demand in that region is enough to regularly en…
West Hills Lab Outreach Still Thrives in California
By Robert Michel | From the Volume X No. 13 – September 29, 2003 Issue
CEO SUMMARY: Now in its seventh year, the lab outreach program at West Hills Hospital and Medical Center in Southern California continues to produce significant revenues. The goal was to target physicians’ offices in the medical campus around the hospital and provide them a local laborato…
Healthcare Premiums Climb At Double-Digit Rate for 2004
By Robert Michel | From the Volume X No. 13 – September 29, 2003 Issue
EXPECTATIONS that health insurance premiums will increase by an average of 12% to 15% for 2004 have captured plenty of media attention recently. Employers and health insurers are currently negotiating premiums for 2004. There is consensus among healthcare experts that 2004 will be the fourth consecu…
CURRENT ISSUE
Volume XXXIII, No. 4 – March 23, 2026
A federal court ruling has established a safe harbor for clinical labs when they run tests ordered by physicians. Lab leaders should examine this briefing for pitfalls. Also, it turns out that providers may be ordering inappropriate vitamin D tests, according to one expert.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized